Compounds > 2-n-hexyl-5-n-propylresorcinol
Page last updated: 2024-12-08

2-n-hexyl-5-n-propylresorcinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-n-hexyl-5-n-propylresorcinol: produced by Pseudomonas B 9004; RN & N1 from 9th CI; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID197183
CHEMBL ID496837
CHEBI ID168034
SCHEMBL ID5881393
MeSH IDM0058034

Synonyms (20)

Synonym
39341-78-1
CHEBI:168034
db-2073
2-hexyl-5-propylbenzene-1,3-diol
antibiotic db 2073
resorcinol, 2-hexyl-5-propyl-
1,3-benzenediol, 2-hexyl-5-propyl-
db 2073
2-hexyl-5-propyl-1,3-benzenediol
brn 1964593
CHEMBL496837
unii-e3bw82ch2t
e3bw82ch2t ,
2-n-hexyl-5-n-propylresorcinol
SCHEMBL5881393
2-hexyl-5-propyl resorcinol
LMPK15030002
DTXSID10192566
Q5204376
2-hexyl-5-propyl-resorcinol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkylbenzeneA monocyclic arene that is benzene substituted with one or more alkyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID376305Antifungal activity against Candida albicans assessed as total inhibition of cell growth/spore germination after 24 hrs2006Journal of natural products, Apr, Volume: 69, Issue:4
Antimicrobial dialkylresorcinols from Pseudomonas sp. Ki19.
AID376304Antifungal activity against Fusarium culmorum assessed as total inhibition of cell growth/spore germination after 72 hrs2006Journal of natural products, Apr, Volume: 69, Issue:4
Antimicrobial dialkylresorcinols from Pseudomonas sp. Ki19.
AID376314Antibacterial activity against Staphylococcus aureus assessed as detectable inhibition of growth after 24 hrs2006Journal of natural products, Apr, Volume: 69, Issue:4
Antimicrobial dialkylresorcinols from Pseudomonas sp. Ki19.
AID376307Antifungal activity against Drechslera sorokiniana assessed as detectable inhibition of growth after 48 hrs2006Journal of natural products, Apr, Volume: 69, Issue:4
Antimicrobial dialkylresorcinols from Pseudomonas sp. Ki19.
AID376311Antibacterial activity against Staphylococcus aureus assessed as total inhibition of cell growth/spore germination after 24 hrs2006Journal of natural products, Apr, Volume: 69, Issue:4
Antimicrobial dialkylresorcinols from Pseudomonas sp. Ki19.
AID376306Antifungal activity against Fusarium culmorum assessed as detectable inhibition of growth after 72 hrs2006Journal of natural products, Apr, Volume: 69, Issue:4
Antimicrobial dialkylresorcinols from Pseudomonas sp. Ki19.
AID376309Antifungal activity against Aspergillus fumigatus assessed as total inhibition of cell growth/spore germination after 96 hrs2006Journal of natural products, Apr, Volume: 69, Issue:4
Antimicrobial dialkylresorcinols from Pseudomonas sp. Ki19.
AID376310Antifungal activity against Aspergillus fumigatus assessed as detectable inhibition of growth after 96 hrs2006Journal of natural products, Apr, Volume: 69, Issue:4
Antimicrobial dialkylresorcinols from Pseudomonas sp. Ki19.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
streptomycin
[no description available]		2.0310antibiotic antifungal drug;
antibiotic fungicide;
streptomycins		antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor
enilconazole
enilconazole: RN given refers to parent cpd. enilconazole : A racemate comprising equimolar amounts of (R)- and (S)-enilconazole. A fungicide used to control a wide range of fungi including Tilletia and Helminthosporium spp. on fruit, vegetables and ornamentals. In veterinary medicine, it is used topically for the treatment of fungal skin infections in cattle, dogs, and horses; it is also used by inhalation for the treatment of aspergillosis in ostriches.. 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole : A member of the class of imidazoles in which the hydrogen at position 1 is replaced by a 2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl group.		2.0310dichlorobenzene;
ether;
imidazoles
amphotericin b
Amphotericin B: Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.. amphotericin B : A macrolide antibiotic used to treat potentially life-threatening fungal infections.		2.0310antibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic		antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
ConditionIndicatedRelationship StrengthStudiesTrials